Gx. Chen et al., Selection of insulinoma cell lines with resistance to interleukin-1 beta- and gamma-interferon-induced cytotoxicity, DIABETES, 49(4), 2000, pp. 562-570
Engineered insulinoma cell lines may represent an alternative to isolated i
slets for transplantation therapy of type 1 diabetes. Success of this appro
ach may require development of cell lines that can withstand cytokine-media
ted damage. To this end, we have cultured INS-1 insulinoma cells in increas
ing concentrations of interleukin-1 beta (IL-1 beta) + gamma-interferon (IF
N-gamma), with approximate weekly iterations over an 8-week period. Based o
n the C,N diphenyl-N'-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium br
omide (MTT) viability assay the selected cells, termed INS-1(res), were 100
%, viable after 5 days of treatment with 10 ng/ml of IL-1 beta. These cells
were also 78 +/- 1.2%, viable after 5 days of exposure to the combination
of 10 ng/ml IL-1 beta and 100 U/ml IFN-gamma, whereas parental INS-1 cells
treated in the same manner were only 0.3 +/- 0.03% viable. INS-1(res) cells
were also resistant to treatment with supernatants from activated rat peri
pheral blood mononuclear cells, whereas only 20% of parental INS-1 cells su
rvived such treatment. The resistance to IL-1 beta conferred by this proced
ure was stable, whereas the partial resistance to IFN-gamma was transient b
ut reinducible by culture in the presence of cytokines. Stable transfection
of INS-1(res) cells with a plasmid containing the human insulin cDNA and e
xpansion of the transfected colonies in the absence of cytokines produced c
ell lines that were on average more resistant to IL-1 beta + IFN-gamma (53
+/- 11%) than similarly transfected clones derived from parental INS-1 cell
s (15 +/- 7%). Importantly, several INS-1(res)-derived clones retained the
capacity to secrete insulin in response to glucose concentrations over the
normal physiological range, With regard to the mechanism by which selection
was conferred, we found normal levels of IFN-gamma receptor mRNA, but a 60
% reduction in expression of the IL-1 receptor type I (IL-1R1) in INS-1(res
) cells compared with parental INS-1 cells. IL-1 beta signaling through p38
MAP kinase was found to be normal in INS-1(res) cells, suggesting that the
ir expression of IL-1R1 is sufficient to maintain cytokine action, However,
normal IL-1 beta-mediated translocation of NF-kB and induction of inducibl
e nitric oxide synthase expression and nitric oxide production was severely
impaired in the INS-1(res) cell lines, suggesting a mechanism for the IL-1
beta resistance. In sum, this study defines a strategy for isolation of cy
tokine-resistant beta-cell lines and provides a new system for studying the
mechanisms by which such resistance can be achieved.